The global digital pathology market is an established market in the developed countries as well as in developing countries across the world. The use of digital pathology utilizes the image based surrounding that helps in the acquisition, management and interpretation of the pathology information created by the digital glass slide. The applications of life sciences involves high quantity of scanning glass slides, quantitative analysis of whole slide images, instant internet based consultations with expertise pathologists and protected archival of pathology data. Scanners by some of the market players provide the above mentioned features.

Wearables technology products have been accepted well in the consumer medical tech field but the healthcare industry has questioned their utility beyond heart rate tracking and for more crucial applications of healthcare. This means that the market was limited to consumers and healthcare providers till now.

Rising number of cases of corona virus is increasing the demand of PPE across the globe. According to the UNICEF, the demand for PPE products has surged 1000-2000 fold. Earlier in 2017-2019, the annual demand for coveralls and gowns by low and middle-income countries sourced by UNICEF did not exceed 50,000 units. However, the current demand for three months of these products is around 25 million. Similarly, for different types of facemasks, earlier the annual average procurement sourced by UNICEF was not more than 25000 units but now it has exceeded 55 million due to this target disease.

Plasma medications are produced from human blood plasma (plasma). Plasma can be obtained from administration of whole blood (recovered plasma) or apheresis procedures (plasma source). The source is plasma a wide range of medicinal therapies products used for treatment and the prevention of various treatment-causing injuries and diseases often associated with a protein deficiency state. Convalescent Plasma Therapy (CP), a classic adaptive immunotherapy, has been used in the prevention and treatment of many infectious diseases for over a century. In the past two decades, CP therapy has been successfully used in the treatment of the 2009 SARS, MERS and H1N1 pandemic with satisfactory efficacy and safety. In 2014, the World Health...

The coronavirus (COVID-19) pandemic is having a dramatic impact on the in-vitro diagnostics (IVD) including technologies such as PCR, NGS, ELISA, clinical chemistry, rapid-tests, hematology, hemostasis, urinalysis, microbiology testing, and others. Currently, in-vitro diagnostic is the only diagnosis used by the healthcare professionals in order to detect the spread of corona virus across the globe. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East and Africa up to South America. The COVID- 19 has been declared as a pandemic by WHO due to its increased spread across the globe. After the declaration of the pandemic, various countries announced the complete lockdown such as the U.S...

The need of immunoassay kit for reliable COVID 19 test led the country’s government to reduce the price of these tests, so that individual belonging to any economic status can afford such tests.

Healthcare robots can play a critical role in the current pandemic by reducing human involvement and shielding health staff from infection. This will involve measuring patients' temperatures, disinfecting equipment, measuring specimen swabs and delivering much-needed psychological assistance to patients in isolation. Researchers are now beginning to illustrate the cyclical aspect of technology right after the recession. The COVID-19 contraction would accelerate labor-replacement automation as business sales see a fall. This might have arrived during the 'cultural shock' as automation eliminates low-skilled jobs.

The fast-moving Coronavirus disease (COVID-19) of 2019 affects all of us severely. The most significant descriptions of how we live our lives are terms such as "social distancing," "self-quarantine," and "flattening the curve." Hopefully, this pandemic will soon be resolved, but its permanent effects will change the way we live and work. We are becoming increasingly used to remote and practical technologies. Although we will ultimately return to our daily activities, we will rely on these approaches for the complexities of the post-COVID-19 world in many working environments.

The COVID-19 crisis has shifted innumerable perceptions regarding daily activities as well as has led to a significant reassessment towards well-being and protection. On the other side, it represents lucrative opportunities to novel healthcare solutions including wearable technology. The pandemic has triggered a fear of infection from not just the virus but other neglected elements that impact health. The adoption of wearables and accompanying apps has escalated significantly as it helps the users to feel aware and protected. Moreover, as normal life is thrown out of control, these wearables restore a sense of control by providing real time information of health signals.

The outbreak of COVID-19 is having a huge impact on the healthcare industry majorly the PPE (Personal Protective Equipment). PPE includes gloves, mask, gown, goggles, N95 respirators, and hand sanitizer. Currently, it is the only preventive measure for the healthcare professional to prevent themselves from the spread of corona virus.